Max Richter
Impact in
-
- Tryptophan and brain disorders
-
- Alzheimer's disease research and treatments
Papers in
-
- Cell death mechanisms and regulation 3
- Signaling Pathways in Disease 2
-
- Alzheimer's disease research and treatments 4
- Co-authors
- Ulrike Müller (4 shared papers)Inna N. Lavrik (7 shared papers)Kamil Seyrek (4 shared papers)Wickliffe C. Abraham (1 shared paper)Bruce G. Mockett (1 shared paper)Nikita V. Ivanisenko (3 shared papers)Martin Körte (2 shared papers)Steve Zalcman (1 shared paper)
- Journals
- The EMBO Journal (3 papers)Cancer (1 paper)BMC Genomics (1 paper)BioMed Research International (1 paper)Frontiers in Cell and Developmental Biology (1 paper)
- Partner nations
- GermanyRussiaSwitzerland
In The Last Decade
Max Richter
14 papers receiving 429 citations
Peers
Comparison fields: 5 of 81
- Biological Psychiatry 25
- Physiology 159
- Developmental Neuroscience 20
- Behavioral Neuroscience 17
- Neurology 39
Countries citing papers authored by Max Richter
This map shows the geographic impact of Max Richter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Richter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Richter more than expected).
Fields of papers citing papers by Max Richter
This network shows the impact of papers produced by Max Richter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Richter. The network helps show where Max Richter may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Richter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 97 | |
| 2 | 1993 | 63 | |
| 3 | 2018 | 61 | |
| 4 | 2019 | 52 | |
| 5 | 2020 | 45 | |
| 6 | 2021 | 35 | |
| 7 | 1989 | 20 | |
| 8 | 2019 | 15 | |
| 9 | 2021 | 12 | |
| 10 | 2020 | 12 | |
| 11 | 2019 | 10 | |
| 12 | 2021 | 9 | |
| 13 | 2025 | 1 | |
| 14 | 2021 | 1 |
About Max Richter
Max Richter is a scholar working on Molecular Biology, Physiology, Immunology, Oncology and Epidemiology, having authored 14 papers that have together received 433 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (4 papers), Cell death mechanisms and regulation (3 papers), Autophagy in Disease and Therapy (3 papers), Signaling Pathways in Disease (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), Genetics and Neurodevelopmental Disorders (2 papers), Infection Control and Ventilation (1 paper) and Galectins and Cancer Biology (1 paper). The work is most often cited by research in Biological Psychiatry (25 citations), Physiology (159 citations), Developmental Neuroscience (20 citations), Behavioral Neuroscience (17 citations) and Neurology (39 citations). Max Richter has collaborated with scholars based in Germany, Russia and Switzerland. Frequent co-authors include Ulrike Müller, Inna N. Lavrik, Kamil Seyrek, Wickliffe C. Abraham, Bruce G. Mockett, Nikita V. Ivanisenko, Martin Körte, Steve Zalcman, Susann Ludewig and David P Wolfer. Their work appears in journals such as The EMBO Journal, Cancer, BMC Genomics, BioMed Research International and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.